HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
241,366
Total Value
$0.00
P&L
+inf% (+$15,309,845.38)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Option to Purchase Common Stock | Derivative | Feb 9, 2026 | Grant/Award | 53,847 | $0.00 | $0.00 | 53,847 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 50,013 | $0.00 | $0.00 | 50,013 | Direct | โ | View Details | |
Director | Performance Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 19,807 | $0.00 | $0.00 | 51,171 | Direct | โ | View Details | |
Director | Performance Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 24,985 | $0.00 | $0.00 | 144,400 | Direct | โ | View Details | |
Director | Performance Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 92,714 | $0.00 | $0.00 | 92,714 | Direct | โ | View Details |